About US

About us

2025
2025.11
Cerviray AI (On‑Device) MFDS Class III license modification approved
2025.10
Cerviray AI registered with Vietnam MOH
2025.09
Cerviray AI registered with Thailand TFDA
2025.05
URO dot AI designated as Innovative Medical Technology by MHW
2025.01
URO dot AI 'MFDS Class II' approval Urolithiasis AI Software
URO dot AI  Designated as Innovative Medical Device No. 81 (MFDS)  Non‑reimbursable market entry
2024
2024.12
Urolithiasis AI Software designated as 'Innovative Medical Device'
2024.08
Cerviray AI registered with Kuwait MOH 
Cerviray AI U.S. AI patent granted
2024.05
GIGA dot AI designated as 'Innovative Medical Device' No. 63 (MFDS)
2024.02
GIGA dot AI MFDS 'Class III' certification completed
2023
2023.11
Gastro endoscopy AI software approved as 'MFDS Class III' device 
Cerviray AI registered with Serbia MMDA 
Cerviray AI registered with UAE MOH
2023.08
Cerviray AI (AI Cervical Cancer Diagnosis System) patents granted in Indonesia
Cerviray AI (AI Cervical Cancer Diagnosis System) patents granted in Japan
2023.07
Cerviray AI registered with Bolivia AGEMED
2023.05
Prime Minister’s Award at Medical Device Day 
Obtained In vitro diagnostic medical devices GMP Certification
2023.04
Selected as a high-growth company for the 2023 SW High-Growth Club
2023.01
Cerviray US FDA 510K 'Class  II' approval registration completed
2022
2022.12
Awarded K‑Regulatory Free Zone Biz Partnering Gangwon Director’s Prize
Cerviray AI registered with Vietnam MOH
2022.08
Cerviray AI registered with Indonesia LKPP (National Procurement Agency)
2022.06
Cerviray AI MFDS 'Class III' approval for AI Cervical Cancer Diagnostic Software
2022.05
Registered with Uzbekistan MOH (Colposcope)
Participated in Dr. Answer 2.0 AI Precision Medical Solution Project
2022.04
Participated in KHIDI project for building big data specialized for critical care and developing AI-based CDSS
KIAT Multi‑Agency Technology Commercialization Program selected
NRF Commercialization Support Program selected (MSIT)
2022.03
Cerviray AI research paper published in SCI‑level journal
2022.01
Selected for Regulatory Free Zone Innovation Program 
Registered with Indonesia MOH (AI, Colposcope)
2021
2021.11
Selected among Top 100 National R&D Excellence Achievements
2021.10
Won 1st Prize in Medical Technology at Go Global Awards 2021 (ITC)
2021.09
Signed lead manager agreement for KOSDAQ IPO with Korea Investment & Securities
2021.08
Series A funding

Korea Investment & Securities, Fine Value Asset Management

2021.07
Selected as a service provider for the AI convergence medical imaging interpretation system support project
Selected as a business operator for the Gangwon precision medicine regulatory free zone project
2021.05
Selected as one of the ‘Korea’s Top 1000 Innovative Companies’
Final selection for the Global Accelerating Support Program by the Ministry of SMEs and Startups
2021.04
NIPA -  Final selection for the New Southern Policy Project 
KIAT Multi‑Agency Technology Commercialization Program selected
NIPA -Final selection for the AI Convergence Medical Imaging Interpretation System National Project
2021.03
Selected for the AI Convergence Medical Imaging Interpretation System Project by the National IT Industry Promotion Agency
2020
2020.12
Selected for the Promising Export SME Designation Program (Second Half)
Awarded MFDS Minister Prize 
ISO 13485 Certification acquired
Received Minister’s Commendation from the Ministry of SMEs and Startups
Signed a Domestic Joint Project Contract with Korea Phil Medical Foundation
2020.11
Received Excellence Award at the 7th Korea Software Product Quality Awards
Received Chairman’s Award from the Korea Technology Finance Corporation at the Smart Korea Awards
2020.08
 KGMP 'Class III' certification obtained (MFDS)
2020.07
 Selected as Top Hottest Artificial Intelligence Company by CIO Advisor
Big Data R&D Project winner
2020.06
Selected for the Overseas Certification Technology Development Project by the Ministry of SMEs and Startups with Seoul Metropolitan Government and Invest Seoul
2020.05
Selected as an investment attractee by Seoul VC Connect
Selected for the Global Software Development Support Program by the Institute for Information and Communications Technology Planning and Evaluation
Selected for the Pre‑High‑Growth Software Club Program
2020.01
Received MFDS Medical Device Manufacturer License
2019
2019.11
 MFDS Import License granted
Digital Colposcope MFDS Certification
2019.09
Final selection for the AI Technology Commercialization Project by the Seoul Metropolitan Government
2019.05
Final selection for the TIPA Startup Growth Technology Development Project – AI‑based Cerebral Aneurysm Rupture Prediction System
Final selection for the NIPA – Development of an Intelligent Stroke Diagnosis System using AI and Genomic Data with a Portable Carotid Ultrasound Device Set
2019.03
Strategic partnership with Chuncheon Sacred Heart Hospital for AI Neuro‑disease solutions
2019.01
Completed hardware prototype of the Digital Colposcope (electronic speculum)
2018
2018.10
Final selection for the Korea‑Canada Joint Research Project – AI Technology Collaboration based on Quantum Computing
Final selection for the National R&D Project by the IITP
2018.02
 Registered as an incubation company at the Incheon Center for Creative Economy and Innovation
2018.01
Korea Daily Brand Excellence Award (Medical Sector)
2017
2017.12
Awarded Minister of Science and ICT Commendation
2017.08
Joint Research Agreement with Bundang Seoul National University Hospital

 Conducted a study to build expert reading data for developing AI for cervical image interpretation

2017.05
Selected for Startup Growth R&D Project (Deep‑Learning‑based Cervical Cancer Imaging Solution)
 Selected for the China Membership Program by the Incheon Center for Creative Economy and Innovation
 Selected for the Overseas Localization Support Program by the NIPA
2016
2016.05
Selected for the K‑Global Startup Competition – Next‑Generation Deep Learning‑Based Interpretation System
2015
2015.12
Selected as one of the K‑Global 300 Promising Companies certified by the Minister of Science, ICT and Future Planning
Certified as a venture company by the Korea Technology Finance Corporation
2015.06
Selected for K‑ICT Step‑by‑Step Re‑Challenge Project (Beacon‑based Hospital Marketing Solution)
2015.03
Secured startup funding from the Korea Technology Finance Corporation
2014
2014.06
AIDOT Established
닫기
로그인하셔야 본 서비스를 이용하실 수 있습니다.